Streptococcus bovis/gallolyticus Induce the Development of Colorectal Cancer by A.S. Abdulamir et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
17 
Streptococcus bovis/gallolyticus Induce the 
Development of Colorectal Cancer  
 A.S. Abdulamir1,2, R.R. Hafidh1,3 and F..Abu Bakar1 
1Institute of Bioscience, University Putra Malaysia, Serdang, Selangor,  
2Microbiology Department, College of Medicine, Alnahrain University PO, Baghdad,  
3Microbiology Department, College of Medicine, Baghdad University,  
1Malaysia 
2,3Iraq 
1. Introduction  
The role, of microbial agents and the infection of the intestinal mucosa in the carcinogenesis, 
or the development of colorectal cancer (CRC) is one of the hot topics in the field of CRC 
where much research has been done. However, this topic has long been underestimated by 
most of the related books. This chapter is intended to cover the relationship of CRC 
development with bacteria implicated in the development of CRC such as S. bovis, S. 
gallolyticus, S. equines, S. infantarius, E .coli, C. difficile…etc. However, S. gallolyticus and S. 
bovis will be discussed thoroughly in this chapter as they are considered the prototype for 
intestinal microorganisms related to CRC and colorectal premalignant lesions.  
Studying CRC association with infection of intestinal mucosa is not complete without 
studying the underlying mechanisms. There is compelling evidence that CRC is largely 
affected by the status of intestinal bioflora. CRC has been found to be affected by certain 
microbial agents that have particular characteristics capable of inducing dysplastic changes 
in intestinal mucosa. However, the underlying mechanisms of the association of implicated 
infective agents with CRC development are yet not clear. In addition, the role of oncogenic 
factors, cell growth factors, and pro-inflammatory cytokines in the association of bacterial 
infection in intestinal mucosa with CRC has not yet been clarified well. Therefore, the 
current chapter attempts to scrutinize the nature and the underlying mechanisms of the 
association of infective agents represented by S. bovis/gallolyticus with CRC. Nevertheless, 
the association of S. bovis/gallolyticus with CRC is still under controversy regarding whether 
the bacterial infection of intestine, along with associated bacteremia/endocarditis, is a 
consequence or the etiological factor of CRC. Hence, this chapter also attempts to explore 
the facts available in the field to assess which scenario is more favorable for the association 
of S. bovis/gallolyticus with CRC namely, the consequence or the etiology scenario.  
One of the bacterial agents that have been most associated with cancer is Streptococcus bovis 
(S. bovis). S. bovis has been shown to be important in human health because 25 to 80% of 
patients with S. bovis bacteremia had also colorectal tumor, and the incidence of association 
of colonic neoplasia with S. bovis endocarditis was shown to be 18 to 62% (Gupta et al., 2009; 
Kok et al., 2007; Leport et al., 1987; Malkin et al., 2008; Reynolds et al., 1983; Wilson et al., 
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1981; Zarkin et al., 1990). Later, it was shown that a new species resembling S. bovis is 
actually most implicated in CRC development; S. bovis infecting human intestine has been 
named as S. gallolyticus (Osawa et al., 1995). More precisely, S. bovis biotype I and II/2 
isolates were shown to be S. gallolyticus (Devriese et al., 1998). Accordingly, S. bovis biotype I 
was replaced by S. gallolyticus subspecies gallolyticus and biotype II/2 was replaced by S. 
gallolyticus subspecies pasterianus and S. gallolyticus subspecies macedonicus (Schlegel et al., 
2003). S. gallolyticus subspecies gallolyticus, rather than other related taxa, have been found to 
be constantly associated with underlying colorectal cancer.  
2. The association of colorectal cancer with S. bovis/gallolyticus 
bacteremia/endocarditis  
S. bovis, has long been linked to the development of CRC. However, the extent, nature, and 
basis of this association are still not completely understood. S. bovis/gallolyticus became 
important in human health since it was shown that 25 to 80% of patients who presented S. 
bovis/gallolyticus bacteremia had also a colorectal tumor and the incidence of association of 
colonic neoplasia with S. bovis/gallolyticus endocaditis was shown to be 18 to 62% (Gupta et 
al., 2009; Kok et al., 2007; Leport et al., 1987; Malkin et al., 2008; Murray & Roberts, 1978; 
Reynolds et al., 1983; Wilson et al., 1981; Zarkin et al., 1990). The knowledge that there is an 
association between endocarditis from S. bovis/gallolyticus and carcinoma of the colon has 
important clinical implications (Boleij et al., 2009a; Kok et al., 2007). The majority of the 
studies that found clues on the association of S. bovis/gallolyticus with CRC was in Europe 
and North America. Actually, it is true that the association of S. bovis/gallolyticus bacteremia 
with colorectal cancer has been found variable among different geographical and ethnic 
groups (Boleij et al., 2009a), but this association is not restricted to certain geographical 
region. A recent study done in Malaysia found that 48.6% of S. bovis isolates was found in 
patients with colonic polyps, adenocarcinomas, inflammatory bowel diseases. It was also 
found that colorectal cancer incidence was 24.7%, adenocarinomas accounting for 51% with 
the highest incidence in the sigmoid part of the colon(Al-Jashamy et al., 2010). This study 
indicates a strong relationship between S. bovis/gallolyticus and colonic premalignant as well 
as malignant lesions in a geographical region that was considered of low incidence for CRC 
cases associated with bacterial infections. Moreover, an epidemiological study conducted in 
Hong Kong on S. bovis bacteremia and its relation to colorectal cancer, confirmed the 
association of S. bovis/gallolyticus with CRC and found that S. bovis biotype II/2 is the 
dominant in Hong Kong rather than biotype I (S. gallolyticus) which is dominant in Western 
countries (Lee et al., 2003).  
Thorough studies on S. bovis have shown that associations between S. bovis bacteraemia and 
carcinoma of the colon and infective endocarditis were biotype-specific. It was shown that 
there is 94% association between S. bovis biotype I bacteraemia and infective endocarditis 
and 71% association between S. bovis biotype I bacteraemia and colonic carcinoma. On the 
other hand, it is only 18% association between S. bovis biotype II bacteraemia and infective 
endocarditis and 17% association between S. bovis biotype II bacteraemia and colonic 
carcinoma (Murray & Baron, 2007). Following the description of S. gallolyticus, Devriese 
team used whole-cell protein analysis to show that all six bacterial isolates studied, which 
were derived from patients with endocarditis and identified by conventional techniques as 
S. bovis, were in fact S. gallolyticus. Therefore, they suggested that S. gallolyticus is more likely 
to be involved in human infections than is S. bovis (Devriese et al., 1998). 
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The underlying mechanisms for the association of CRC with S. bovis/gallolyticus 
bacteremia/endocarditis have been obscure for a long time. The possible reason behind that, 
maybe, S. bovis/gallolyticus is a member of intestinal flora in 2.5 to 15% of individuals which 
usually make scientists counteract any malicious role of this bacteria (Burns et al., 1985; 
Murray & Roberts, 1978). It was conceived in the beginning that the ulceration of neoplastic 
lesions might form a pathway for the microorganism to enter the bloodstream (Gupta et al., 
2009). However, the latter scenario of bacterial access into the circulation does not explain 
the cases of patients with infectious endocarditis and non-ulcerated colonic polyps (Cutait et 
al., 1988). Furthermore, colonic neoplasia may arise years after the presentation of the 
condition of bacterial bacteremia or infectious endocarditis (Fagundes et al., 2000; Zarkin et 
al., 1990). For this reason, patients with infectious endocarditis and normal colonoscopy may 
be included in the group who present risk for developing colonic cancer because of the late 
appearance of such lesions after the infectious episode of S. bovis/gallolyticus (Fagundes et al., 
2000). Moreover, in supporting the second scenario, it has been shown that the relative risk 
of developing infectious endocarditis from S. bovis/gallolyticus in the presence of carcinoma 
of the colon is merely 3 to 6% (Bisno & 12.ed. New York: , 1991) while 60 to 75% of patients 
with endocarditis by S. bovis/gallolyticus simultaneously present malignant gastrointestinal 
disease that was not previously diagnosed (Grinberg et al., 1990).  
3. The association of premalignant colorectal lesions with  
S. bovis/gallolyticus 
There is a high incidence of colorectal cancer in individuals with polyps; about 90% of 
preinvasive neoplastic lesions of the colorectum are polyps or polyp precursors, namely 
aberrant crypt foci (Nielsen et al., 2007). Neoplastic polyps are often referred to more 
specifically as adenomas or adenomatous polyps (Srivastava et al., 2001). Adenomatous 
polyps are considered as good and few surrogate end point markers for colorectal cancer 
(Kelly et al., 1989; Nielsen et al., 2007). 
It would be of interest to substantiate any relationship between bacterial colonic carriage, 
colonic polyps and the type of polyp and its malignant potential (Boleij et al., 2009a; Schlegel 
et al., 2003). Contrary to the more commonly reported association between S. 
bovis/gallolyticus bacteremia and colorectal cancer, a link to pre-neoplastic adenomatous 
polyps was less frequently reported (Burns et al., 1985; Ellmerich et al., 2000a). Nevertheless, 
the relationship between colorectal bacterial infection and the progressive development of 
malignant disease in pre-neoplastic adenomatous polyps was supported by recent reports 
(Abdulamir et al., 2009; Kahveci et al., 2010; Murinello et al., 2006). Interestingly, benign 
lesions (diverticulosis, inflammatory bowel disease, cecal volvulus, perirectal abscess 
hemorrhoids, benign polyps) were found to be mildly associated with intestinal bacterial 
infections such as S. bovis/gallolyticus while a strong relationship between more malignant 
diseases of the colon (cancer and neoplastic polyps) and S. bovis/gallolyticus was found 
(Abdulamir et al., 2009; Burns et al., 1985; Klein et al., 1979; Nielsen et al., 2007; Reynolds et 
al., 1983; Smaali et al., 2008). It was also revealed that S. bovis/gallolyticus septicemia and/or 
endocarditis is selectively related to the presence of villous or tubulovillous adenomas in the 
large intestine (Fagundes et al., 2000; Smaali et al., 2008). In fact, Villous and tubulovillous 
adenomas, which have risk of malignant transformation about 15-25%, were found to be 
associated with S. bovis/gallolyticus bacteria more often than other types of adenomas (Bond, 
2005). For example, Hoen team performed a case-control study on subjects underwent 
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colonoscopy comparing between patients with S. bovis/gallolyticus endocarditis and sex- and 
age- matched unaffected patients. This study showed that colonic adenomatous polyps were 
present in twice as many cases as controls (15 of 32 vs 15 of 64), and colorectal cancer was 
present approximately 3 times as often (3 of 32 vs 2 of 64) (Hoen et al., 1994). However, 
surprisingly, another study (Devis et al., 1989) found that the association between S. 
bovis/gallolyticus and adenoma was more evident than that with colorectal cancer; they 
reported that 36% of positive blood cultures of S. bovis/gallolyticus were found in 
proliferative lesions (15% of cancers and 21% of adenomas). A recent study (Abdulamir et 
al., 2009) supported this concept showing that the level of S. bovis/gallolyticus IgG antibodies 
in adenoma patients is much higher than in both colorectal cancer patients and control 
subjects. However, other reports did not reveal the same thing. (Burns et al., 1985) stated 
that the incidence of S. bovis/gallolyticus carriage in all colons with polyps was intermediary 
between normal colons and colons with carcinoma although the difference did not achieve 
statistical significance. 
Regarding the fecal carriage of S. bovis/gallolyticus, (Burns et al., 1985) demonstrated that 
highly premalignant polyps were found to be more often associated with S. bovis/gallolyticus 
carriage than were benign polyps. A clue for the active role of intestinal bacteria in the 
development of CRC, S. bovis/gallolyticus endocarditis, rather than other members of group 
D Streptococcus, showed special predilection to colonic lesions. It was found that of 77 
infections with group D Streptococcus endocarditis, colonic polyps and colonic carcinoma 
were significantly more frequent in the S. bovis/gallolyticus group (67 and 18%) respectively 
than in the Enterococcus group (21 and 2%) respectively (Leport et al., 1987). This indicates 
that certain bacteria have role in the etiology of CRC development from premalignant poly 
lesions.  
The remarkable association between adenomatous polyps and S. bovis/gallolyticus seems to 
be of importance due to the compelling evidence that colon cancer progresses from normal 
tissue to adenoma and then to carcinoma through an accumulation of genetic alterations 
(Baron & Sandler, 2000). Although ulceration of the neoplastic lesion might form a pathway 
for the S. bovis/gallolyticus to enter the bloodstream (Gupta et al., 2009), the association of S. 
bovis/gallolyticus bacteremia with non-ulcerated colonic polyps indicates an 
etiological/promoter role of these bacteria in polyps progression (Cutait et al., 1988; Konda 
& Duffy, 2008). The possibility of S. bovis/gallolyticus to act as a promoter for the 
preneoplastic lesions is worthy to be considered. A remarkable study supported this 
hypothesis using rats treated with S. bovis wall extracted antigens (WEA), rats treated with a 
chemical carcinogen, rats treated with both WEA and chemical carcinogen, and untreated 
rats. All groups of rats did not develop hyperplastic colonic crypts except for the group 
treated with both WEA and the chemical carcinogen; about 50 % rats of this group 
developed neoplastic lesions (Ellmerich et al., 2000a). This indicated that S. bovis bacteria 
might exert their pathological activity in the colonic mucosa only when preneoplastic lesions 
are established. Another model supporting the promoter effect of S. bovis/gallolyticus, H. 
pylori infection and subsequent inflammation seem most likely to be promoters in the 
multistep development of carcinoma (from chronic gastritis to atrophy, intestinal 
metaplasia, dysplasia, and, ultimately, cancer) rather than the causative agents (Leung, 
2006). Therefore, the association of S. bovis/gallolyticus in etiology and/or acceleration of 
the transformation of aberrant crypts to adenoma and to cancer is now being 
reconsidered.  
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Accordingly, the knowledge of association of colorectal adenoma with S. bovis/gallolyticus 
has important clinical implications. If the lesion can be discovered at an early stage, curative 
resection may become possible (Waisberg et al., 2002). Thus, bacteremia due to S. 
bovis/gallolyticus should prompt rigorous investigation to exclude both endocarditis and 
tumors of the large bowel (Beeching et al., 1985; Konda & Duffy, 2008). Therefore, it was 
concluded that the discovery of a malignant or premalignant proliferative lesion in one third 
of the cases justifies the exploration of the colon by barium enema and/or colonoscopy in 
the case of S. bovis/gallolyticus septicemia (Beeching et al., 1985; Konda & Duffy, 2008). This 
would empirically aid for the early detection of adenoma in the gastrointestinal tract before 
its progression to cancer.  
4. The proposed mechanisms for the development of colorectal cancer by  
S. bovis/gallolyticus 
Chronic inflammation is associated with malignant changes. Host genetic polymorphisms of 
the adaptive and innate immune response play an important role in bacteria-induced cancer 
formation (El-Omar, 2006; Hou et al., 2007; Karin & Greten, 2005). Therefore, studying the 
immunological responses to chronic bacterial infections is likely to yield important clues 
on both the mechanisms of persistent infection and the relationship between 
inflammation and cancer formation (Ernst et al., 2006; Monack et al., 2004). Clinical 
studies have shown that the use of non-steroidal anti-inflammatory drugs is associated 
with a reduced risk of gastric cancer (Dai & Wang, 2006). However, bacteria implicated in 
carcinogenesis, like S. bovis/gallolyticus, might use several mechanisms for carcinogenesis 
such as the colonization of epithelial surfaces and the use of virulence factors to 
chronically affect host cell cycle control, apoptosis, cell junction integrity or cell polarity 
((Vogelmann & Amieva, 2007). 
4.1 Clues for etiological role 
The big question is whether bacteria play an etiological role in the carcinoma of colon or it is 
merely marker of the disease. There are many clues collectively provide evidence for the 
etiological role of bacteria in colon cancer development. The striking association between 
bacteremia caused by S. bovis biotype I and both colonic neoplasia (71%) and bacterial 
endocarditis (94%), rather than bacteremia caused by closely related organisms such as S. 
bovis variant and S. salivarius, suggests the possibility of specific bacterium-host interactions 
(Ruoff et al., 1989). Moreover, the appearance of new colonic lesions 2-4 after the incidence 
of S. bovis/gallolyticus bacteremia/endocarditis, provides more evidence that S. 
bovis/gallolyticus is not merely a consequence of the tumor lesion (Wentling et al., 2006). In 
terms of pathogenesis, as S. bovis/gallolyticus is a transient normal flora in the gut, 
researchers have postulated that the increased bacterial load of S. bovis/gallolyticus in colon 
might be responsible for its association with colon cancer. Several studies have shown that 
increased stool carriage of S. bovis/gallolyticus is particularly found in patients with 
inflammatory bowel diseases or malignant/premalignant lesions of the colon while S. 
bovis/gallolyticus bacteria were rarely isolated from normal subjects (Teitelbaum & 
Triantafyllopoulou, 2006). Another clue supporting the etiological role of S. bovis/gallolyticus, 
patients diagnosed with colon cancer have only 3–6% chance to develop S. bovis/gallolyticus 
endocarditis (zur Hausen, 2006), which is far lower than the percentage of the detection of 
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colorectal cancer in patients with S. bovis/gallolyticus bacteremia/endocarditis, which his 
more than 70%.  
4.2 Mechanisms of the proposed etiological role of S. bovis/gallolyticus in the 
development of colorectal cancer 
4.2.1 Selective adherence to intestinal tumor cells 
Some bacteria such as S. bovis/gallolyticus are frequent colonizers of the intestinal tract, 
which can also cause endocarditis. However, their ability to adhere to and colonize host 
tissues is largely unknown. It was found that S. bovis/gallolyticus bacteria possess collagen-
binding proteins and pili that are responsible for adhesion to colorectal mucosa as well as to 
endocardium (Sillanpaa et al., 2009). On the other hand, another study (Boleij et al., 2009b) 
found a histone-like protein A on the surface of S. bovis/gallolyticus able to bind heparan 
sulfate proteoglycans at the colon tumor cell surface during the first stages of infection; this 
cell surface protein in S. gallolyticus acts as one of the main heparin-binding proteins that is 
largely responsible for bacteria selective adhesive potential as well as entry to the blood 
circulation. Another study assessing 17 endocarditis-derived human isolates, identified 15 S. 
gallolyticus subspecies gallolyticus, one S. gallolyticus subspecies pasteurianus (biotype II/2) 
and one S. infantarius subspecies coli (biotype II/1) for their in vitro adherence to 
components of the extracellular matrix; this study provided evidence that S. gallolyticus 
subspecies gallolyticus bacteria possess very efficient adherence characteristics to the host 
extracellular matrix; this bacteria showed powerful adherence to collagen type I and type 
IV, fibrinogen, collagen type V, and fibronectin (Sillanpaa et al., 2008). These adherence 
merits render these bacteria successful colonizers in both intestinal and cardiac tissues 
which might explain the association between S. bovis/gallolyticus endocarditis and intestinal 
lesions.  
4.2.2 Changing the intestinal bacterial flora and alterations in the local vascular 
attributes  
Increased incidence of hepatic dysfunction has been reported in patients with bacterial 
infectious endocarditis (Fagundes et al., 2000). It has been speculated that S. bovis/gallolyticus 
affects portal circulation through bacterial translocation, thereby determining hepatic 
alterations. Modifications in the hepatic secretion of bile salts and the production of 
immunoglobulins contribute towards increasing the participation of S. bovis/gallolyticus in 
abnormal changes in the bacterial flora of the colonic lumen which might then promote 
carcinogenesis of the intestinal mucosa (Beeching et al., 1985; Gupta et al., 2009). 
It has been suggested that alterations in local conditions and disruption of capillary channels 
at the site of neoplasm allowed S. bovis/gallolyticus to proliferate and gain entry into blood 
stream (Biarc et al., 2004; Ellmerich et al., 2000a; Nguyen et al., 2006). The local action of 
cytokines or of chemical mediators able to promote vasodilatation and the enhancement of 
capillary permeability, may support the bacterial entry at tumor sites, and increase bacterial 
adherence to various cells (Biarc et al., 2004; Ellmerich et al., 2000b).  
4.2.3 Promoting/propagating effect on preneoplastic lesions and inflammation-driven 
carcinogenesis  
A series of interesting experiments was conducted for investigating the role of S. 
bovis/gallolyticus in the initiation and development of colorectal cancer. Chemical carcinomas 
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were induced by giving adult rats intraperitonial injections of azoxymethane (15 mg/kg 
body weight) once per week for 2 weeks. Fifteen days (week 4) after the last injection of the 
carcinogen, the rats received, by gavage twice per week during 5 weeks, either S. bovis (1010 
bacteria) or wall-extracted antigens (WEAs) (100 µg). One week after the last gavage (week 
10), it was found that administration of either S. bovis or its antigens promoted the 
progression of preneoplastic lesions into neoplastic lesions through the increased formation 
of hyperproliferative aberrant colonic crypts, which enhanced the expression of proliferation 
markers and increased the production of IL-8 in the colonic mucosa (Biarc et al., 2004; 
Ellmerich et al., 2000b). Therefore, this study suggests that S. bovis/gallolyticus bacteria act as 
potential promoters of early preneoplastic lesions in the colon of rats, and their cell wall 
proteins are more potent inducers of neoplastic transformation than the intact bacteria. This 
study also revealed that the development of colonic adenomas increased remarkably in 50% 
of the tested rats and the expression level of proliferation markers, the polyamine content 
and proliferating cell nuclear antigen was also increased (Biarc et al., 2004; Ellmerich et al., 
2000a; Nguyen et al., 2006). This provided extra evidence that S. bovis/gallolyticus acts more 
likely as promoter/propagator of colorectal carcinoma rather than just a consequence of the 
tumor lesion. These studies might suggest that bacteria, in general, are often not capable to 
induce cancer without the presence of other predisposing factors for carcinogenesis. In this 
regard, it was conceived that the transformation process of colorectal tumors associated 
with S. bovis/gallolyticus is more likely accompanied with long-lasting bacterial 
promoting/propagating effect along with chronic inflammation status in intestinal mucosa. 
This conclusion was supported by Balkwill et al. stating that tumor formation might require 
independent mutations in oncogenic signaling pathways in addition to chronic 
inflammatory conditions which are needed to promote transformation process (Balkwill et 
al., 2005). 
In vitro experiments showed that the binding of S. bovis wall extracted antigens to various 
cell lines including human colonic cancer cells (Caco-2) stimulated the production of 
inflammatory cytokines by those cells (Biarc et al., 2004; Nguyen et al., 2006). Earlier it was 
found that the production of inflammatory cytokines in response to S. bovis/gallolyticus, such 
as TNF-α, IL-1ß and IL-6, and the chemokine IL-8, were found to contribute to the normal 
defense mechanisms of the host (Ellmerich et al., 2000b; Travers & Rosen, 1997) leading to 
the formation of nitric oxide and free radicals such as superoxide, peroxynitrites, hydroxyl 
radicals as well as alkylperoxy radicals (Nguyen et al., 2006; Ohshima & Bartsch, 1994). 
Owing to their potent mutagenicity, all these molecular species can contribute to the 
neoplastic processes by modifying cellular DNA. On the other hand, in the colonic mucosa, 
the production of angiogenic factors, such as IL-8, triggered by S. bovis/gallolyticus antigens 
may also favor the progression of colon carcinogenesis (Eisma et al., 1999; Ellmerich et al., 
2000b; Norrby, 1996). This resembles H. pylori infection for the development of chronic 
inflammation in the gastric mucosa (Dixon et al., 1996); therefore, it seems that chronic 
infection and subsequent chronic inflammation are responsible for the maintenance and 
development of pre-existing neoplastic lesions (Shacter & Weitzman, 2002).  
Moreover, it was found that WEAs of S. bovis induced in vitro overexpression of 
cyclooxygenase-2 (COX-2) (Biarc et al., 2004; Nguyen et al., 2006). COX-2, via 
prostaglandins, promotes cellular proliferation and angiogenesis and inhibits apoptosis, 
thus acting as a promoter in the cancer pathway (Tafte & Ruoff, 2007). It is noteworthy to 
mention that non-steroidal anti-inflammatory drugs (NSAIDS) were found to decrease the 
relative risk of gastrointestinal carcinomas and their main target was found to be 
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cyclooxygenase 2 (COX-2) that is over-expressed in up to 85% of colorectal adenocarcinomas 
(Kargman et al., 1995). Moreover, (Haqqani et al., 2000) revealed that the activation of 
leukocytes by S. bovis/gallolyticus was found to release various other inflammatory 
mediators (NO, free radicals, peroxynitriles, etc.) which could interfere directly or indirectly 
with the cell proliferation process. A recent study conducted by our team, S. gallolyticus has 
shown a specific association with colorectal cancer and colorectal adenoma when compared 
with the more dominant intestinal bacteria, B. fragilis. This provided evidence for a possible 
important role of S. gallolyticus in the carcinogenesis of colorectal cancer from pre-malignant 
polyps. In addition, it was also found that NF-κB and IL-8 rather than other transformation 
factors p21, p27 and p53 act as important mediators for the S. gallolyticus-associated 
transformation of adenoma to carcinoma (Abdulamir et al., 2009). Moreover, it was 
concluded that NF-κB exerts most probably a promoting carcinogenic effect and IL-8 exerts 
mainly an angiogenic-based propagating effect on colorectal mucosal cells (Abdulamir et al., 
2009). In addition, a more recent study done by our team showed a direct and active role of 
S. bovis/gallolyticus in colorectal cancer development through inflammation-based sequel of 
tumor development or propagation via IL-1, COX-2, and IL-8 (Abdulamir et al., 2010). By 
these studies, a strong relationship was shown to be evident between the proinflammatory 
potential of S. bovis/gallolyticus bacteria and their carcinogenic properties confirming the 
linkage between inflammation and colon carcinogenesis.        
In the presence of WEAs proteins of S. bovis/gallolyticus, Caco-2 cells exhibited enhanced 
phosphorylation of 3 classes of mitogen activated protein kinases (MAPKs) (Biarc et al., 
2004). Several reports showed that MAPKs activation stimulates cells to undergo DNA 
synthesis and cellular uncontrolled proliferation (Hirata et al., 2001; Ihler, 1996; Smith & 
Lawson, 2001). Therefore S. bovis/gallolyticus proteins could promote cell proliferation by 
triggering MAPKs which might increase the incidence of cell transformation and the rate of 
genetic mutations. Furthermore MAPKs, particularly p38 MAPK, can induce COX-2 which 
is an important factor in tumorogenesis (Lasa et al., 2002; Wang & Dubois, 2010) and up-
regulate the expression of NFkB which is considered the central link between inflammation 
and carcinogenesis (Karin & Greten, 2005). Accordingly, the pro-inflammatory potential of 
S. bovis/gallolyticus proteins and their pro-carcinogenic properties as well as the chronic 
inflammation and the leucocytic recruitment driven by S. bovis/gallolyticus provide strong 
evidence on the possible causal link between S. bovis/gallolyticus inflammation and colonic 
carcinogenesis. Therefore, the above data support the hypothesis that colonic bacteria can 
contribute to cancer development particularly via chronic infection/inflammation where 
bacterial components may interfere with cell function for long time (Biarc et al., 2004; Wang 
& Dubois, 2010). 
5. Selective colonization of S. bovis/gallolyticus in colorectal mucosa 
The association of bacteria with colorectal cancer has always been described through the 
incidence of S. bovis/gallolyticus bacteremia and/or endocarditis (Leport et al., 1987; Murray 
& Roberts, 1978; Reynolds et al., 1983; Wilson et al., 1981; Zarkin et al., 1990). On the other 
hand, little bacteriological research has been done on elucidating the colonization of S. 
bovis/gallolyticus in tumor lesions of colorectal cancer in order to confirm or refute, on solid 
bases, the direct link between colorectal cancer and S. bovis/gallolyticus (Norfleet & Mitchell, 
1993; Potter et al., 1998). A recent study of by our team was conducted to assess the 
colonization of S. bovis/gallolyticus bacteria in colon by detecting S. bovis/gallolyticus DNA in 
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colorectal cancer tumors using advanced molecular assays (Abdulamir et al., 2010). In 
Abdulamir et al. study, S. bovis/gallolyticus-specific primers and probes were used in PCR 
and in situ hybridization (ISH) assays, respectively, to detect S. bovis/gallolyticus DNA from 
feces, tumor mucosal surfaces, and from the inside of tumor lesions. In addition, 
bacteriological isolation of S. bovis/gallolyticus was conducted to isolate S. bovis/gallolyticus 
cells from feces, tumor mucosal surfaces, and from the inside of tumor lesions. In this study, 
S. bovis/gallolyticus was successfully isolated, via bacteriological assays, from tumorous and 
non-tumorous tissues, of colorectal cancer patients with bacteremia, 20.5% and 17.3%, and of 
colorectal cancer patients without bacteremia, 12.8% and 11.5%, respectively while only 2% 
of control tissues revealed colonization of S. bovis/gallolyticus.  
On the other hand, the positive detection of S. bovis/gallolyticus DNA, via PCR, in tumorous 
and non-tumorous tissues of colorectal cancer patients with bacteremia, 48.7 and 35.9%, and 
without bacteremia, 32.7 and 23%, respectively, was remarkably higher than that in control 
tissues, 4%. And the positive detection of S. bovis/gallolyticus DNA, via ISH, in tumorous and 
non-tumorous tissues of colorectal cancer patients with bacteremia, 46.1 and 30.7%, and 
without bacteremia 28.8 and 17.3%, respectively was remarkably higher than that in control 
tissues, 2%. In addition, by using absolute quantitative PCR for S. bovis/gallolyticus DNA, the 
S. bovis/gallolyticus count, in terms of copy number (CN), in tumorous and non-tumorous 
tissues of colorectal cancer patients with bacteremia, 2.96-4.72 and 1.29-2.81 log10 CN/g, 
respectively, and colorectal cancer patients without bacteremia, 2.16-2.92 and 0.67-2.07 log10 
CN/g, respectively, showed significantly higher level of colonization in tumorous than in 
non-tumorous tissues and in colorectal cancer patients with bacteremia than in colorectal 
cancer patients without bacteremia. Accordingly, this study provided several new 
observations. First, S. bovis/gallolyticus colonizes selectively tumorous tissues of colorectal 
cancer  patients rather than normal mucosal tissues. Second, the colonization of S. 
bovis/gallolyticus is mainly found inside tumor lesions rather than on mucosal surfaces of 
tumors. Third, the titer of the colonizing S. bovis/gallolyticus bacteria in colorectal cancer 
patients with bacteremia/endocarditis was much higher than in patients without 
bacteremia/endocarditis; this explains why some colorectal cancer patients develop 
concomitant bacteremia of S. bovis/endocarditis while others do not. Actually, the newly 
discovered selective colonization of S. bovis/gallolyticus explains the conclusions of an earlier 
report (Tjalsma et al., 2006) stating that colonic lesions provide a suitable microenvironment 
for S. bovis/gallolyticus colonization resulting in silent tumor-associated infections that only 
become apparent when cancer patients become immunocompromised, as in bacteraemia, or 
have coincidental cardiac valve lesions and develop endocarditis.  
6. Using S. bovis/gallolyticus in the early detection of colorectal tumors 
For a long time, it has been conceived that there is a need to establish a good screening test 
for colonic cancer patients, particularly a test which could detect early lesions. It has been 
suggested that the presence of antibodies to certain bacterial antigens or the presence of 
certain bacterial antigens in the bloodstream may act as markers for carcinogenesis of the 
colon (Beeching et al., 1985; Potter et al., 1998). The serology-based detection of colorectal 
cancer has advantage on other tests such as fecal occult blood which is neither sensitive nor 
specific or carcinoembryonic antigen which is regularly detectable in only advanced 
diseases (Tafte & Ruoff, 2007). Darjee and Gibb stated that it might be possible to develop a 
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test to screen patients for the presence of colonic cancer by measuring IgG antibody titer of 
S. bovis/gallolyticus (Darjee & Gibb, 1993). Hence, since the association between slow 
evolving bacterial inflammation and colorectal cancer takes long time, it is prudent to seek 
specifically for IgG antibodies. Furthermore, IgG antibodies reflect an image of the past and 
the chronic presence of S. bovis/gallolyticus antigens in the circulation. 
Some studies showed the possibility of constructing a serology test for the successful 
detection of colonic cancer based on the detection of antibody to S. bovis/gallolyticus or 
Enterococcus faecalis (Abdulamir et al., 2009; Groves, 1997). Therefore, a simple ELISA test 
with no more than 2 ml of patient’s blood might be a good candidate for screening high risk 
individuals for the presence of premalignant neoplastic polyps, adenomas, and cancers. 
However, some other studies of antibody response to S. bovis/gallolyticus and other 
streptococci have found that antibody is detectable in endocarditis but not in either clinically 
insignificant bacteremias (Burnie et al., 1987), or colonic cancers ((Kaplan et al., 1983) by 
using immunoblotting, immunoflourescence and other techniques. In a recent study of our 
team (Abdulamir et al., 2009), the serum level of IgG antibodies against S. gallolyticus 
subspecies gallolyticus antigens adsorbed on solid phase of ELISA was found to be 
significantly higher in colorectal cancer patients than in control subjects. This is in full 
agreement with the study of (Darjee & Gibb, 1993) who showed that patients with colonic 
cancer had higher median IgG antibody titers to S. bovis and E. faecalis preparations than did 
the control samples. Accordingly, the applicability of using ELISA as a cheap and effective 
assay for the early detection of colorectal cancer using IgG antibodies against S. 
bovis/gallolyticus has been tested and proven (Abdulamir et al., 2009). Therefore, the early 
detection of colorectal cancer using simple means of testing opens doors to monitor high 
risk groups of colorectal cancer more efficiently.  
7. Conclusions 
Colorectal tumors, adenoma or carcinoma, are associated remarkably with bacterial 
infections of intestine. The manifestation of this association is usually observed as 
concurrent bacteremia or endocarditis of S. bovis/gallolyticus. The association of S. 
bovis/gallolyticus bacteria with colorectal cancer is more likely etiological in nature rather 
than a consequence of the disease. The proposed etiological role of S. bovis/gallolyticus in the 
development of colorectal cancer might be attributed to many factors including selective 
adhesion potential of S. bovis/gallolyticus to tumor tissues, the selective colonization of S. 
bovis/gallolyticus inside tumor tissues, the suitable microenvironment of tumors for S. 
bovis/gallolyticus proliferation, the local disruption of tumor tissues and capillaries which 
allow the entry of S. bovis/gallolyticus into blood circulation leading to bacteremia and 
endocarditis, and the bacterially-induced cytokines and transcriptional factors, such as IL-1, 
IFN-γ, IL-8, and NFkB, which induce and propagate the chronic inflammatory environment 
which promote/propagate premaligant intestinal lesions to malignant ones. This is a very 
important role of S. bovis/gallolyticus in the carcinogenesis of colorectal tissues since the 
majority of cases of colorectal cancer are sporadic cancers arising through the 
transformation of normal colorectal tissues to premalignant lesions, adenomas, and finally 
to malignant tissues. Besides, the early detection of colorectal adenomas or carcinomas via 
detection of S. bovis/gallolyticus DNA or their specific IgG antibodies might be of high value 
in screening the high risk groups for colorectal cancer. More in-depth research is needed to 
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exploit the association of bacteria with colorectal cancer in terms of early diagnosis of the 
disease as well as understanding the bacterial carcinogenic potential to determine the 
appropriate means to prevent and/or treat bacterially-associated cancers.  
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